Per Eriksson

Per Eriksson

Professor Emeritus
E-postadress: per.eriksson@ki.se
Telefon: +46852481563
Besöksadress: BioClinicum, Plan 8,Karolinska Universitetssjukhuset Solna, 17176 Stockholm
Postadress: K2 Medicin, Solna, K2 Kardio Björck H, 171 77 Stockholm
Del av:

Om mig

  • Per Eriksson är professor i kardiovaskulär medicin vid Karolinska Institutet sedan 2007. Hans forskning handlar om de underliggande molekylära mekanismerna för utvecklingen av aortaaneurysm (pulsåderbråck). Aortaaneurysm är en tyst sjukdom, som oftast märks först i det akuta läget vid aortadissektion eller rupturerad aorta. Båda tillstånden är dödliga om patienten inte opereras omedelbart.

Artiklar

Alla övriga publikationer

Forskningsbidrag

  • Swedish Research Council
    1 januari 2021 - 31 december 2023
  • Swedish Heart-Lung Foundation
    1 januari 2019 - 31 december 2021
  • Swedish Research Council
    1 januari 2017 - 31 december 2020
  • Fondation Leducq
    1 januari 2012
    Bicuspid aortic valve (BAV), a condition in which there are two valve leaflets instead of the normal three, is the most common congenital cardiac malformation, affecting from 1% to 2% of the population.  It appears to be highly heritable, is more common in males than females, and is frequently associated with other aortic pathology, such as ascending aortic aneurysm. The goal of the MIBAVA network is to identify factors that affect the clinical outcome of patients with BAV, with particular attention to the progression of aortic aneurysm.  The scope of the research program will span natural history and epidemiologic studies, exploration and application of advanced imaging techniques, use of advanced genetic methods to identify disease-related genes and pathways, basic science investigations to identify predisposing mechanisms at the biochemical, cellular and tissue level, and the complementary use of various model systems.  With progress in understanding the etiology of aneurysm formation, the network will turn to the search for novel therapeutic strategies and the development of individualized treatment protocols.
  • Swedish Research Council
    1 januari 2012 - 31 december 2016
  • Swedish Research Council
    1 januari 2009 - 31 december 2011

Anställningar

  • Professor Emeritus, Medicin, Solna, Karolinska Institutet, 2026-2028
  • Professor, Senior, Medicin, Solna, Karolinska Institutet, 2025-2025
  • Professor, Medicin, Solna, Karolinska Institutet, 2006-2024

Examina och utbildning

  • Docent, Molekylär medicin, Karolinska Institutet, 1999

Nyheter från KI

Kalenderhändelser från KI